These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9400835

  • 1. SPIO-enhanced 2D-TOF MR angiography of the portal venous system: results of an intraindividual comparison.
    Reimer P, Marx C, Rummeny EJ, Müller M, Lentschig M, Balzer T, Dietl KH, Sulkowski U, Berns T, Shamsi K, Peters PE.
    J Magn Reson Imaging; 1997; 7(6):945-9. PubMed ID: 9400835
    [Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced 3D-MRA of the upper abdomen with a bolus-injectable SPIO (SH U 555 A).
    Reimer P, Allkemper T, Matuszewski L, Balzer T.
    J Magn Reson Imaging; 1999 Jul; 10(1):65-71. PubMed ID: 10398979
    [Abstract] [Full Text] [Related]

  • 3. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD, Böck JC, Rautenberg K, Beier J, Ebert W, Felix R.
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [Abstract] [Full Text] [Related]

  • 4. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ, Hammerstingl R, Schwarz W, Kümmel S, Müller PK, Balzer T, Lauten MJ, Balzer JO, Mack MG, Schimpfky C, Schrem H, Bechstein WO, Neuhaus P, Felix R.
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [Abstract] [Full Text] [Related]

  • 5. [Three-dimensional MR angiography of HCC and portal and hepatic veins using superparamagnetic iron oxide].
    Ono Y, Marukawa T, Ashikaga R, Inoue M, Fujii K, Araki Y, Ishida O.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Feb; 58(3):97-8. PubMed ID: 9558852
    [Abstract] [Full Text] [Related]

  • 6. Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis.
    Macarini L, Marini S, Murrone M, Ettorre GC.
    Radiol Med; 2004 Feb; 108(1-2):92-106. PubMed ID: 15269693
    [Abstract] [Full Text] [Related]

  • 7. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M, Schnorr J, Abramjuk C, Wagner S, Pilgrimm H, Hünigen H, Hamm B.
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [Abstract] [Full Text] [Related]

  • 8. [Dynamic and static MRI using superparamagnetic MRI contrast medium Resovist for visualizing primary and secondary liver tumors].
    Vogl TJ, Schwarz W, Hammerstingl R, Kümmel S, Balzer JO, Mack MG, Diebold T, Balzer T, Shamsi K, Bechstein WO, Schrem H, Neuhaus P, Felix R.
    Rofo; 1997 Sep; 167(3):264-73. PubMed ID: 9376555
    [Abstract] [Full Text] [Related]

  • 9. Hepatic MRI with SPIO: detection and characterization of focal liver lesions.
    Reimer P, Tombach B.
    Eur Radiol; 1998 Sep; 8(7):1198-204. PubMed ID: 9724439
    [Abstract] [Full Text] [Related]

  • 10. [Superparamagnetic iron oxide enhanced MR angiography of the portal vein system].
    Schmitz SA, Albrecht T, Jensen K, Wolf KJ.
    Rofo; 2000 Jan; 172(1):51-4. PubMed ID: 10719463
    [Abstract] [Full Text] [Related]

  • 11. Clinical results with Resovist: a phase 2 clinical trial.
    Reimer P, Rummeny EJ, Daldrup HE, Balzer T, Tombach B, Berns T, Peters PE.
    Radiology; 1995 May; 195(2):489-96. PubMed ID: 7724772
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M, Ito K, Shimizu A, Fujita T, Onoda H, Yamatogi S, Washida Y, Matsunaga N.
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [Abstract] [Full Text] [Related]

  • 13. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
    Stroszczynski C, Gaffke G, Gretschel S, Rambow A, Jost D, Schlecht I, Schneider U, Schicke B, Hohenberger P, Gebauer B, Felix R.
    Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
    [Abstract] [Full Text] [Related]

  • 14. Comparison of Gadolinium-BOPTA and Ferucarbotran-enhanced three-dimensional T1-weighted dynamic liver magnetic resonance imaging in the same patient.
    Wersebe A, Wiskirchen J, Decker U, Schick F, Dietz K, Müller-Schimpfle M, Claussen CD, Pereira PL.
    Invest Radiol; 2006 Mar; 41(3):264-71. PubMed ID: 16481909
    [Abstract] [Full Text] [Related]

  • 15. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
    Abe Y, Yamashita Y, Namimoto T, Tang Y, Takahashi M.
    Radiat Med; 2000 Mar; 18(2):97-105. PubMed ID: 10888042
    [Abstract] [Full Text] [Related]

  • 16. MR imaging of the liver with Resovist: safety, efficacy, and pharmacodynamic properties.
    Kopp AF, Laniado M, Dammann F, Stern W, Grönewäller E, Balzer T, Schimpfky C, Claussen CD.
    Radiology; 1997 Sep; 204(3):749-56. PubMed ID: 9280254
    [Abstract] [Full Text] [Related]

  • 17. RES-specific imaging of the liver and spleen with iron oxide particles designed for blood pool MR-angiography.
    Bremer C, Allkemper T, Baermig J, Reimer P.
    J Magn Reson Imaging; 1999 Sep; 10(3):461-7. PubMed ID: 10508309
    [Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D.
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [Abstract] [Full Text] [Related]

  • 19. Characterization of focal liver lesions with superparamagnetic iron oxide-enhanced MR imaging: value of distributional phase T1-weighted imaging.
    Lee JM, Kim CS, Youk JH, Lee MS.
    Korean J Radiol; 2003 Nov; 4(1):9-18. PubMed ID: 12679629
    [Abstract] [Full Text] [Related]

  • 20. Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries.
    Holland GA, Dougherty L, Carpenter JP, Golden MA, Gilfeather M, Slossman F, Schnall MD, Axel L.
    AJR Am J Roentgenol; 1996 Apr; 166(4):971-81. PubMed ID: 8610584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.